ArticleCPT: pharmacometrics & systems pharmacology2019
Modeling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib.
Ronald Niebecker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it